Design Issues of Randomized Phase II Trials and a Proposal for Phase II Screening Trials

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

2004 • 11,185 citations

EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

2004 • 9,201 citations

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

2001 • 5,189 citations

Optimal two-stage designs for phase II clinical trials

1989 • 3,494 citations

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

2001 • 1,267 citations

Modelling Survival Data in Medical Research

1994 • 1,036 citations

One-Sample Multiple Testing Procedure for Phase II Clinical Trials

1982 • 987 citations

Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer

2004 • 773 citations

Randomized phase II clinical trials.

1985 • 469 citations

Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

2000 • 458 citations

Comparison of Gemcitabine Versus the Matrix Metalloproteinase Inhibitor BAY 12-9566 in Patients With Advanced or Metastatic Adenocarcinoma of the Pancreas: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

2003 • 382 citations

A Simple Approximation for Calculating Sample Sizes for Comparing Independent Proportions

1980 • 362 citations

Clinical Trial Designs for Cytostatic Agents: Are New Approaches Needed?

2001 • 323 citations

Planning the size and duration of a clinical trial studying the time to some critical event

1974 • 287 citations

Seamlessly Expanding a Randomized Phase II Trial to Phase III

2002 • 128 citations

Optimal two-stage screening designs for survival comparisons

1990 • 118 citations

Clinical Trial Designs for the Early Clinical Development of Therapeutic Cancer Vaccines

2001 • 111 citations

Incorporating historical control data in planning phase II clinical trials

1990 • 81 citations

A flexible design for multiple armed screening trials

2001 • 80 citations

False Positive Rates of Randomized Phase II Designs

1999 • 76 citations

An efficient design for phase III studies of combination chemotherapies.

1985 • 67 citations

Data Monitoring Committees and Interim Monitoring Guidelines

1999 • 59 citations

Selection Designs for Pilot Studies Based on Survival

1993 • 58 citations

New designs for the selection of treatments to be tested in randomized clinical trials

1994 • 53 citations

Calibrated phase II clinical trials in oncology

1986 • 52 citations

A design for phase II testing of anticancer agents within a phase III clinical trial

1988 • 30 citations

Interferon‐α‐2a with or without 13‐cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma

2004 • 29 citations

A sequential phase II/III trial for binary outcomes

1990 • 24 citations

Picking the winners in a sea of plenty.

2002 • 24 citations

Phase II trials in the EORTC

1997 • 17 citations